BLM and cancer: Interestingly, patients with the Bloom’s syndrome have an average lifespan of 25 years [30], and BLM-deficient cells display a high sister chromatid exchange (SCE) ratio that is positively linked to mutation rate and cancer incidence [31,49,50].